NCT06818955 2025-02-12
OOTER
Tongji Hospital
Phase 2 Not yet recruiting
Clinical Trials
3 trialsNCT06483672 2024-07-03
LungBrain001
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Not yet recruiting
NCT04965831 2021-07-16
Furmonertinib as Perioperation Therapy in Stage IIIA-IIIB (N1-N2) Resectable EGFR Mutated Lung Adenocarcinoma (FRONT)
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Not yet recruiting